This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ERNEST JAWETZ, M.D., Ph.D.

AMA Arch Intern Med. 1954;93(6):850-862.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE ADMINISTRATION of cortisone to severely ill patients often results in marked, though transient, symptomatic improvement, suppression of fever, and apparent reduction in the "toxic state." Physicians therefore are tempted to employ cortisone as an aid in treatment in the hope of tiding a patient over the severest part of an illness until other therapeutic measures can take effect. It is generally known * that cortisone and corticotropin tend to promote the spread of infections and to activate latent infectious processes. Therefore antimicrobial agents are usually administered together with the hormone in such instances to "cover" the potential deleterious effect of cortisone on an existing infection. It is assumed that the hormone will not interfere with the therapeutic efficacy of the antimicrobial agents. This assumption rests on scanty evidence. Several investigators found that cortisone or corticotropin enhances experimental infections with pneumococci or streptococci in laboratory animals but that large doses . . . [Full Text PDF of this Article]

Author Affiliations
With the Technical Assistance of E. R. Merrill, B.A. SAN FRANCISCO

From the Departments of Microbiology, Medicine, and Pediatrics, University of California School of Medicine.

Footnotes
Supported in part by grants from the National Institutes of Health (E-214) and Burroughs Wellcome & Company, Inc.

References 1 and 2. References 3-7. References 10 and 11.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?